Overall, these results suggest that targeting the mechanisms involved in ICD and its associated molecular pathways, such as HSP90AA1 and P2RX7, may be a promising approach to developing novel therapeutic strategies for AD. The gene discussed is P2RX7; the disease is Alzheimer disease.